Sabby Management, LLC Biophytis Sa Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.98 - $2.57 $13,613 - $35,699	-13,891 Reduced 17.85%	63,928 $72,000
Q1 2022 May 16, 2022	SELL	$2.5 - $5.37 $71,895 - $154,430	-28,758 Reduced 26.98%	77,819 $196,000
Q4 2021 Feb 14, 2022	BUY	$4.86 - $8.37 $16,106 - $27,738	3,314 Added 3.21%	106,577 $569,000
Q3 2021 Nov 15, 2021	BUY	$7.93 - $10.6 $97,102 - $129,797	12,245 Added 13.45%	103,263 $893,000
Q2 2021 Aug 16, 2021	SELL	$10.2 - $15.21 $13,535 - $20,183	-1,327 Reduced 1.44%	91,018 $964,000
Q1 2021 May 17, 2021	BUY	$12.8 - $17.02 $1.18 Million - $1.57 Million	92,345 New	92,345 $1.18 Million

Ticker BPTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,382,400
Market Cap $115M
Description
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.